Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia

Leukemia

Volumn 11, Issue 10, 1997, Pages 1661-1664

  Estey, E ^a,b   Thall, P ^a   Kantarjian, H ^a   Pierce, S ^a   Kornblau, S ^a   Keating, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

APL; BMI; Obesity

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; ETHNIC GROUP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0030710239     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400783     Document Type: Article

References (17)

1. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83: 10-25.
2. Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 1996; 87: 308-313.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-625.
4. Dalton W Jr, Stass SA. A morphologic and cytochemical approach to the diagnosis of acute leukemia. In: Stass SA (ed). The Acute Leukemia: Biologic, Diagnostic, and Therapeutic Determinants. Marcel Dekker: New York, Basel, 1987, p 27.
5. Berdanier C. Obesity. In: Munson PL, Mueller RA, Breese GR (eds). Principles of Pharmacology: Basic Concepts and Clinical Applications. Chapman and Hall: New York, 1995, p 1045.
6. Kobayashi T, Miyawaki S, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Ohmoto E, Oh H, Jinnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Matsuoka A, Tomonaga M, Saito H, Ueda R, Ohno R for the Japan Adult Leukemia Study Group. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. J Clin Oncol 1996; 14: 204-213.
7. Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, Yoshida M, Murakami H, Naoe T, Shimoyama M, Tsukada T, Takeo T, Teshima H, Onozawa Y, Fujimoto K, Kuriyama K, Horiuchi A, Kimura I, Minami S, Miura Y, Kageyama S, Tahara T, Masaoka T, Shirakawa S, Saito H. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. Cancer 1993; 71: 3888-3895.
8. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R, and the Japan Adult Leukemia Study Group. Blood 1995; 85: 1202-1206.
9. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263-270.
10. Mertelsmann R, Thaler HT, To L, Gee TS, McKenzie S, Schauer P, Friedman A, Arlin Z, Cirrincione C, Clarkson B. Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood 1980; 56: 773-781.
11. Keating MJ, Cork A, Broach Y, Smith T, Walters RS, McCredie KB, Trujillo J, Freireich EJ. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res 1987; 11: 119-133.
12. Vital and Health Statistics: Anthropometric Reference Data and Prevalence of Overweight United States 1976-80. DHHS Publication No. (PHS) 87-1688. US Department of Health and Human Services, Public Health Service, National Center for Health Statistics: Hyattsville, MD, October 1987.
13. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. Raven Press: New York, 1994, p 319.
14. Soprano DR, Blaner WS. Plasma retinol-binding protein. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. Raven Press: New York, 1994, p 257.
15. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurements of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med 1995; 1: 1155-1161.
16. Chung WK, Power-Kehoe L, Chun M, Leibel RL. Mapping of the OB Receptor to 1 p in a region of nonconserved gene order from mouse and rat to human. Genome Res 1996; 6: 431-438.
17. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Med 1996; 2: 585-589.